Background-Idiopathic ventricular arrhythmia (VA) can arise from the epicardium near the posteroseptal region (cardiac crux). There are only 2 prior reports describing idiopathic VA from the cardiac crux. The purpose of this study was to characterize the clinical and the electrocardiographic features of idiopathic crux VA. Methods and Results-Crux VA was identified in 18 patients undergoing catheter ablation. We divided patients into 2 groups, those with VA originating from the apical crux (n=9) and the basal crux (n=9). We described the clinical and electrocardiographic characteristics of crux VA as well as the ablation results. Furthermore, we compared clinical features of crux VA with other sites of idiopathic VA. Fifteen crux VA patients (83%) had sustained ventricular tachycardia and 3 patients required implantable cardioverter defibrillator implantation because of syncope. All patients had a left superior axis and 16 patients had R>S wave in V2. In apical crux VA, all patients had a deep S wave in V6 and 8 patients (89%) had R>S wave in aVR. All apical crux patients underwent attempted ablation in the middle cardiac vein without success. In 4 of these patients, epicardial ablation with subxiphoid approach was performed successfully. All basal crux VA patients had either negative or isoelectric pattern in V1 and had R>S in V6. Patients had successful ablation within the middle cardiac vein. Conclusions-Apical versus basal crux VA is identified as a new category of idiopathic VA with distinctive electrocardiographic characteristics; ablation via the middle cardiac vein is effective for eliminating basal crux VA, whereas apical crux VA often requires a subxiphoid epicardial approach. (Circ Arrhythm Electrophysiol. 2014;7:1152-1158.)
R adiofrequency catheter ablation is effective and safe for treatment of idiopathic ventricular arrhythmia (VA) originating from the right ventricular outflow tract (RVOT) and the left ventricular (LV) outflow tract. 1, 2 In general, ≈60% to 80% of idiopathic VA originate from the RVOT and 10% originate from the LV outflow tract or aortic sinuses of Valsalva. 3 Idiopathic VA can also originate from the mitral annulus, the tricuspid annulus, Purkinje-fascicular network, LV papillary muscles, and the moderator band in the right ventricle (RV). [4] [5] [6] Electrocardiographic (ECG) criteria are usually helpful in predicting the site of origin of idiopathic VA. [7] [8] [9] [10] The cardiac crux is a 4-sided pyramidal space located in the posteriorseptal region and bounded by right atrium, left atrium, RV, and LV. This space contains the posterior descending branch of the right coronary artery, the atrioventricular nodal artery, and the middle cardiac vein (MCV). The ECG and clinical characteristics of idiopathic crux VA have been described in only 2 reports involving a small number of patients. 11, 12 The purpose of this study was to characterize further the ECG and clinical characteristics of idiopathic crux VA and to define the effectiveness of and optimal approach for catheter ablation.
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Methods
Study Population
Among 1021 patients treated by catheter ablation for idiopathic VA at 5 medical centers, 18 patients (1.8%) were identified as crux VA. We divided these patients into 2 groups: those with apical crux VA (n=9) and those with basal crux VA (n=9). Basal crux VA was defined based on fluoroscopic images and 3-dimensional activation map as the successful ablation region in the proximal coronary sinus (CS) or in the proximal MCV within 2 cm from the MCV ostium. Apical crux VA was defined that the earliest activation or successful ablation region was the middle MCV >2 cm from the MCV ostium or epicardial space over the cardiac crux with fluoroscopic images and 3-dimensional activation map. All patients had symptomatic idiopathic VA and had a normal ejection fraction (≥55%) with no evidence of significant coronary artery disease by coronary artery angiography or stress test. All patients had no scar area in the ventricle by 3-dimensional voltage map. Furthermore, 10 patients underwent MRI and had no structural heart disease and scar area. We compared the clinical characteristics of those with crux VA (n=18) versus those with other sites of idiopathic VA originating from RVOT, LV outflow tract, mitral annulus, fascicular system, and the papillary muscles (n=251) referred to our medical center (University of California, San Francisco) for catheter ablation. All patients gave written informed consent before catheter ablation.
Twelve-Lead ECG
A 12-lead ECG of ventricular tachycardia (VT) or premature ventricular complexes were recorded before and during the ablation procedure in all patients. We analyzed QRS morphology including the bundle-branch block pattern, frontal plane axis, QRS duration, and precordial maximum deflection index (MDI) during VA. The QRS duration was measured as the interval between the earliest rapid deflections of the ventricular complex in any lead to the latest offset in any lead on the 12-lead ECG. Time to maximum deflection was measured from the onset of QRS complex to the maximum deflection in each precordial lead. The time to maximum deflection was divided by the QRS duration to obtain the MDI. 12 The pseudodelta wave was calculated from the earliest ventricular activation to the start of the earliest fast deflection in any precordial lead. 13
Electrophysiological Study and Catheter Ablation
Standard multielectrode catheters were positioned under fluoroscopic guidance through the femoral vein and placed in the RV apex, Hisbundle region, high right atrium, and CS. Programmed ventricular stimulation was performed from the RV apex and RVOT using ≤3 extrastimuli and burst pacing was also performed. If VT did not occur spontaneously or could not be induced by pacing techniques, isoproterenol was infused intravenously (1-10 μg/min). During episodes of clinical arrhythmias, activation mapping was performed. All patients underwent electroanatomical mapping using the CARTO 3 system (Biosense-Webster, Diamond Bar, CA) or NavX Ensite Velocity (St. Jude Medical Inc, Milwaukee, WI). Mapping and catheter ablation were performed using a 3.5-mm open irrigated-tip ablation catheter (Thermocool Navistar or Navistar RMT, Biosense Webster, Inc) or 4-mm nonirrigated ablation catheters. Irrigated radiofrequency energy was delivered in the power control mode starting at 15 or 20 W in the CS to 30 W on the LV endocardium or over the epicardial surface. Radiofrequency energy was applied at a maximum power ranging between 30 and 50 W, with maximum temperature of 40°C. Nonirrigated radiofrequency energy was delivered with a target temperature of 60°C and maximum power output of 30 W. All patients underwent mapping of posteroseptal LV, proximal CS, and the MCV. We used a 4 French fixed wire catheter with microelectrodes in a distal looped configuration (Revelation Helix, Cardima, Inc) for pace mapping in the MCV in 1 patient. Epicardial mapping was performed in 4 patients using a subxiphoid approach. Coronary angiography was performed in 4 patients who underwent epicardial ablation and patients who underwent ablation in the MCV.
Statistical Analysis
Continuous variables are expressed as the mean±SD, and compared using Wilcoxon rank-sum tests. Categorical variables were expressed as numbers and percentages and were compared with Fisher exact test. Five ECG features were selected based on the underlying electrophysiology and clinical experience to determine test characteristics (including sensitivity, specificity, and positive and negative predictive value) for apical and basal VA and for apical and basal ECG features. P values <0.05 were considered statistically significant.
Results
Baseline Characteristics of Crux VA
The study population consisted of 8 men and 10 women with symptomatic idiopathic crux VA. Fifteen patients had sustained VT (83%) and 3 patients had premature ventricular complexes (17%). Table 1 shows the baseline characteristics of crux VA patients as compared with idiopathic VA originating from RVOT, LV outflow tract, mitral annulus, tricuspid annulus, Purkinje-fascicular network, and the papillary muscles (VA group). Patients with crux VA presented with history of syncope more frequently as compared with the idiopathic VA group (44% versus 20%; P=0.01). Patients with crux VA presented with history of VT more frequently as compared with the idiopathic VA group (83% versus 33%; P=0.0001). Furthermore, patients with crux VA had a wider QRS duration during VA than did those with other form of idiopathic VA (150±27 versus 138±19 ms; P=0.04). All patients presented with a superior axis and QS pattern in II and III, and 16 (89%) presented with R>S wave in V2 ( Figure 1A and 1B). The results of mapping and catheter ablation for idiopathic crux VA are shown in Tables 2 and 3. The mean MDI was 0.62 and 17 patients had pseudodelta wave duration >34 ms.
Apical Crux VA
Of the 9 apical crux VA patients (Table 2) , 5 (55%) presented with syncope and 3 (33%) had an implantable cardioverter defibrillator (ICD) inserted for preventing syncope or sudden cardiac death associated with unstable VT. The patients with ICDs presented with multiple shocks and were referred for VT ablation. Figure 2 shows 2 typical ECG patterns recorded during VT arising from the apical crux. Left panel shows a LBBB with cycle length of 250 ms and right panel shows a RBBB with cycle length of 240 ms. In patients with apical crux VA, the average tachycardia cycle length was significantly faster as compared with basal crux VA (261±28 versus 391±45 ms; P=0.047). For all patients with apical crux VA, V6 showed either a QS pattern or a rS pattern. For 8 of the 9 apical crux VA, an R>S wave was recorded in aVR. Those with RBBB showed a prominent R wave in V1 with transition to rS or qS in V6. Those with LBBB showed early transition in V2 with late transition to rS or qS in V6. Remarkably, the QRS morphology of VA changed spontaneously from RBBB to LBBB in 4 patients with apical crux VA. In the apical crux area ( Table 2) , only 2 of 9 patients had acute success with ablation in the middle MCV (>2 cm from the MCV ostium) and both had recurrent VA the following day. In the other 7 patients, crux VA could not be eliminated even acutely with irrigated ablation in the middle MCV. Among these patients, 4 agreed to undergo percutaneous epicardial ablation over the cardiac crux and all 4 had a successful ablation with no recurrence follow-up period (26±13 months). In patients who underwent epicardial mapping, the earliest ventricular activation was recorded in the cardiac crux region. The average local earliest ventricular activation preceding the onset of the QRS complex was 52±18 ms.
Basal Crux VA
Among patients with basal crux VA (Table 3) , 3 (33%) presented with syncope and none had an ICD. All basal crux VA patients ( Figure 1B) had either negative or isoelectric in V1 and had positive in V6. All 9 basal crux VA exhibited an early transition in V2. In the basal crux, all patients had successful elimination of VA with ablation in the proximal MCV or proximal CS; however, 1 patient had recurrent VA during the follow-up period (24±15 months). Table 4 shows a sensitivity, specificity, and positive and negative predictive values for several variables including LBBB pattern, QRS morphology change during VT, R>S wave in aVR, R>S wave in V5 and R<S wave in V6. Four patients in apical crux VA had 2 types of QRS morphology and we only analyzed ECG morphology with clinical VA. The R<S wave in V6 has a sensitivity of 100%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 100% for predicting a apical crux VA. In the small sample available, the RS wave in V6 might provide discrimination between apical and basal crux VA. We describe a mapping and ablation algorithm for cardiac crux VA based on ECG characteristics ( Figure 5 ). 
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Discussion
Main Findings
This study highlights the variable clinical characteristics and ECG findings in patients with idiopathic VA arising from the cardiac crux. We show that ECG characteristics and ablation site can be used to differentiate apical crux VA from basal crux VA. All patients with crux VA had a superior axis and QS wave in inferior leads, and 16 patients (89%) had a prominent R wave in V2. Positive QRS complex in aVR, negative QRS complex in V6, and RBBB pattern can be used to differentiate apical crux VA from basal crux VA. This form of idiopathic VA can be successfully cured with epicardial ablation via a percutaneous subxiphoid approach or ablation within the MCV.
Anatomy of the Cardiac Crux
The cardiac crux is the posteroseptal region formed by the A-V annulus and interventricular groove. This area has a pyramidal space, which represents the confluence of all 4 cardiac chambers and the CS in their nearest proximity. The anterior aspect is the ventricular-septum, and the posterior walls are formed by the convergence of the left and right atria. [14] [15] [16] [17] This area also encompasses the posterior descending branch of right coronary artery, CS, and the epicardial fat. The basal crux area lies in proximity to the ostium of MCV, whereas the apical crux area lies near the posterior interventricular artery, more inferior and epicardial as compared with the basal crux area. It was previously reported using porcine hearts that ablation sites ≥5 mm away from the coronary vessels was safe. 18 Coronary artery angiography was performed for some patients with basal crux VA and for all patients with apical crux VA who underwent epicardial ablation. Successful epicardial ablation sites were located ≥10 mm away from the right coronary artery and its branches.
Comparison With Previous Studies
ECG criteria are known to be helpful to predict the site of origin for idiopathic outflow tract VA. [6] [7] [8] [9] [10] Surface ECG criteria suggesting an epicardial origin for a given VA include a pseudodelta wave ≥34 ms and MDI ≥0.55. 12, 13, 19 Doppalapudi et al 11 described 4 patients with crux VA (3 patients had LBBB and 1 patient had a RBBB). ECG in that series showed a left superior QRS axis, an abrupt precordial transition in V2, as well as features of epicardial VA including a pseudodelta wave ≥34 ms and MDI ≥0.55. Daniels et al 12 described 3 cases of VT ablated from the cardiac crux. Two cases with LBBB morphology were ablated in the proximal MCV, whereas 1 case with RBBB was ablated in the distal MCV. These results are consistent with the ECG findings in our study. We carefully mapped the RV including the tricuspid annulus in all cases of LBBB crux VA and the LV including the mitral annulus in all cases of crux VA. It is important to distinguish basal crux VA from posteroseptal tricuspid annular VA. Basal crux VA shows a QS pattern in II, whereas tricuspid annular VA shows an rS/RS wave in II. The R wave in V2 is taller and QRS duration is longer in basal crux VA as compared with tricuspid annular VA. Hence, a combination of QS wave in II, R wave in V2, and QRS duration can be used to differentiate basal crux VA from tricuspid annular VA. 5 Furthermore, we distinguished basal crux VA from posteroseptal mitral annular VA. Basal crux VA shows a QS pattern in II, whereas mitral annular VA shows an rS wave in II. Basal crux VA shows a QS pattern in V1 (7 had QS pattern and 1 had rs pattern), whereas mitral annular VA shows a variable pattern including R, qR, and rS. 4 The ECG of patients with basal crux VA looks like an epicardial pre-excited posteroseptal accessory pathway (QS in II and R wave in V6). These patients could be ablated in the proximal MCV or CS. In contrast, those with apical crux VA show a site of origin away from the annulus (QS in V6) and could not be ablated in the MCV. None of the WPW patients in the Takahashi series who were ablated in the middle MCV had QS in V6. 20 In addition, it is possible that insufficient radiofrequency energy was delivered in the MCV as it tapers in its course. Consistent with our findings, previous studies have also found that VA originating from basal inferior LV was characterized by Q waves in inferior leads. 19 Lacroix et al 21 described that ischemic VT originating from posteroseptal LV had a left superior axis with positive QRS morphology in V2, with various QRS morphology in V1. We speculate the mechanisms that the QRS morphology could change abruptly from RBBB to LBBB pattern in the apical crux area. First, the variable QRS morphology in V1 suggests that the exit is only to the LV, because the fact that with LBBB morphology, there is abrupt transition by V2 also suggests this mechanism. Otherwise, the variable QRS morphology in V1 may suggest breakthrough excitation over either the right or the left ventricle. However, further studies will be needed to suppose the latter mechanism.
Catheter Ablation of Idiopathic crux VA
We have shown that this form of idiopathic VA can be cured with catheter ablation and does not require ICD implantation. All basal crux VA was ablated successfully within the proximal MCV. Apical crux VA could not be successfully ablated from the middle MCV (>2 cm) suggesting either a focus remote from the vein or inability to deliver sufficient energy as the middle MCV. Two of 9 apical crux VA patients had acute success with ablation from the middle MCV, and both recurred within 24 hours. Both patients with acute success had the R wave in V6 greater than the other apical crux VA patients, suggesting that QRS morphology in V6 might be the most important predictor of ablation success from within the coronary venous system. A deep S wave in V6 indicated a more apical VA origin and typically required subxiphoid epicardial access for successful ablation. None of our patients had coronary artery injury from ablation. However, because of the variable course of the right coronary artery and its branches within the crux area, coronary angiography should be performed before and after ablation for both basal and apical crux VA. In summary, crux VA represents a distinct idiopathic VA with dimorphic manifestation susceptible to successful epicardial ablation from the venous system or subxiphoid access.
Study Limitations
This study has three limitations. First, we could not completely define the mechanism of VT in some cases. Six patients had a clinical history of exercise or stress as a trigger for their VT, suggesting a triggered mechanism as occurs with idiopathic outflow tract VT. Furthermore, activation mapping looked like a focal pattern with earliest activation in the cardiac crux area. The mechanism of the VA has not been studied systematically, but seems to nonreentrant in most cases. However, further studies will be required to be certain of the mechanism of crux VA. Second, 8 patients did not undergo MRI before ablation and we could not completely exclude epicardial scar by MRI. However, all patients underwent 3-dimensional voltage map and had no scar area in the ventricle. Third, this study had the small number of patients with crux VA and further studies will be required to be certain of the algorithm of crux VA.
Conclusions
We describe a cohort of patients with crux VA that is characterized by QS in inferior leads and RBBB or LBBB morphology with early transition. Those with a basal location are recognized by R>S in V6 compared with those with an apical location that have a large R in aVR and R<S in V6. Ablation is usually successful in the proximal CS or proximal MCV for the basal crux VA, whereas in contrast, epicardial ablation using subxiphoid approach is typically required for the apical crux VA.
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